These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18326111)

  • 1. Enterotoxigenic Escherichia coli: advances in technical and laboratory aspects of research and development of vaccines.
    Wkly Epidemiol Rec; 2008 Mar; 83(10):92-5. PubMed ID: 18326111
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent progress toward an enterotoxigenic Escherichia coli vaccine.
    Svennerholm AM; Lundgren A
    Expert Rev Vaccines; 2012 Apr; 11(4):495-507. PubMed ID: 22551034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel vaccine-adjuvant combination successful against bacterial diarrhea.
    Hum Vaccin Immunother; 2014; 10(12):3428. PubMed ID: 26052587
    [No Abstract]   [Full Text] [Related]  

  • 4. Designing vaccines to neutralize effective toxin delivery by enterotoxigenic Escherichia coli.
    Fleckenstein JM; Sheikh A
    Toxins (Basel); 2014 Jun; 6(6):1799-812. PubMed ID: 24918359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of enterotoxigenic Escherichia coli genomics for vaccine development.
    Sjöling Å; von Mentzer A; Svennerholm AM
    Expert Rev Vaccines; 2015 Apr; 14(4):551-60. PubMed ID: 25540974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against enterotoxigenic Escherichia coli.
    Svennerholm AM; Tobias J
    Expert Rev Vaccines; 2008 Aug; 7(6):795-804. PubMed ID: 18665777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries.
    Wkly Epidemiol Rec; 2006 Mar; 81(11):97-104. PubMed ID: 16671213
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advances in new vaccines against human enterotoxigenic Escherichia coli--A review].
    Xia P; Meng X; Zhu G
    Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):198-208. PubMed ID: 27373068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preface.
    Walker RI; Riddle MS; Clifford A
    Vaccine; 2019 Aug; 37(34):4767. PubMed ID: 31300286
    [No Abstract]   [Full Text] [Related]  

  • 10. An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children.
    Walker RI
    Vaccine; 2015 Feb; 33(8):954-65. PubMed ID: 25482842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
    Zhang W; Sack DA
    Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
    Tobias J; Svennerholm AM
    Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design.
    Fleckenstein JM; Rasko DA
    Methods Mol Biol; 2016; 1403():363-83. PubMed ID: 27076141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in silico chimeric multi subunit vaccine targeting virulence factors of enterotoxigenic Escherichia coli (ETEC) with its bacterial inbuilt adjuvant.
    Nazarian S; Mousavi Gargari SL; Rasooli I; Amani J; Bagheri S; Alerasool M
    J Microbiol Methods; 2012 Jul; 90(1):36-45. PubMed ID: 22525194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines Against Escherichia coli.
    Nesta B; Pizza M
    Curr Top Microbiol Immunol; 2018; 416():213-242. PubMed ID: 30062594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Providing Structure to Enterotoxigenic Escherichia coli Vaccine Development.
    Fleckenstein JM
    J Infect Dis; 2017 Jul; 216(1):1-3. PubMed ID: 28541516
    [No Abstract]   [Full Text] [Related]  

  • 17. Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines.
    Tobias J; Svennerholm AM; Holmgren J; Lebens M
    Appl Microbiol Biotechnol; 2010 Jul; 87(4):1355-65. PubMed ID: 20405124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.
    Jelinek T; Kollaritsch H
    Expert Rev Vaccines; 2008 Jul; 7(5):561-7. PubMed ID: 18564011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of a vaccine candidate expressing enterotoxigenic Escherichia coli (ETEC) adhesins for colibacillosis with a commercial vaccine using a pig model.
    Hur J; Lee JH
    Vaccine; 2012 Jun; 30(26):3829-33. PubMed ID: 22507658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection.
    Ouwehand AC; ten Bruggencate SJ; Schonewille AJ; Alhoniemi E; Forssten SD; Bovee-Oudenhoven IM
    Br J Nutr; 2014 Feb; 111(3):465-73. PubMed ID: 23930950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.